Objectives To evaluate the long-term outcomes, clinical phenotypes and factors associated with complications in Still’s ...
Canakinumab Effective as First-Line Drug for Systemic Juvenile Idiopathic Arthritis Without Steroids
VIENNA — The interleukin 1 receptor antagonist (IL-1RA) canakinumab provided control of systemic juvenile idiopathic arthritis (sJIA) without the use of glucocorticoids for up to a year in most study ...
Juvenile idiopathic arthritis (JIA) is an umbrella term for various inflammatory arthritis diseases that can cause many different symptoms according to the type. It’s also known as juvenile rheumatoid ...
Arthritis is not just an old person's disease. Children can get arthritis too, and some forms can be deadly. July is Juvenile Arthritis Awareness Month. A local boy is doing what he can to spread ...
Investigation into myeloid-related protein 8/14 (MRP8/14) serves as an important next step of translational research to discovering a diagnostic biomarker for systemic juvenile idiopathic arthritis.
NEW YORK--(BUSINESS WIRE)--PIF Partners announced today that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to its proprietary investigational ...
Children with systemic juvenile idiopathic arthritis (sJIA; Still disease) and those with rheumatoid factor (RF)-positive polyarthritis exhibiting high disease activity had higher serum ferritin ...
"Before this, we really didn't understand how common eosinophilia was, and isolated eosinophilia in sJIA patients doesn't necessarily mean they're having an adverse reaction because it happens in ...
In a recent study published in Scientific Reports, researchers identified shared genetic markers and immune system involvement in systemic juvenile rheumatoid arthritis (sJRA) and type 1 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results